Literature DB >> 8985372

Productive and lytic infection of human CD4+ type 1 helper T cells with macrophage-tropic human immunodeficiency virus type 1.

Y Tanaka1, Y Koyanagi, R Tanaka, Y Kumazawa, T Nishimura, N Yamamoto.   

Abstract

It is generally recognized that macrophage-tropic human immunodeficiency virus type 1 (HIV-1) is the predominant population during the acute and asymptomatic phases of HIV-1 infection. Here, we compared the proliferation and syncytium-inducing activities of different HIV-1 strains in primary CD4+ T cells expressing various helper T (Th)-type cytokine profiles. The macrophage-tropic HIV-1 strains HIV-1JR-CSF, HIV-1NFN-SX, and HIV-1SF162 could proliferate vigorously and generate syncytia in primary CD4+ T cells irrespective of their Th subtype, in contrast to the T-cell-line-tropic HIV-1 strains HIV-1NL4-3 and HIV-1IIIB, which favored non-type 1 Th conditions. These results indicate that macrophage-tropic HIV-1 may be more invasive and virulent, since it kills more CD4+ Th1 cells than T-cell-line-tropic HIV-1 during the early stages of HIV-1 infection, when the Th1 immune response is dominant.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8985372      PMCID: PMC191073     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

Review 1.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties.

Authors:  T R Mosmann; R L Coffman
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

2.  Response.

Authors:  J Salk; P A Bretscher; P L Salk; M Clerici; G M Shearer
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

3.  Differential ability of human immunodeficiency virus isolates to productively infect human cells.

Authors:  L A Evans; T M McHugh; D P Stites; J A Levy
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

4.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

Review 5.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

6.  HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay.

Authors:  M Koot; A H Vos; R P Keet; R E de Goede; M W Dercksen; F G Terpstra; R A Coutinho; F Miedema; M Tersmette
Journal:  AIDS       Date:  1992-01       Impact factor: 4.177

Review 7.  Multifactorial nature of human immunodeficiency virus disease: implications for therapy.

Authors:  A S Fauci
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

8.  Differential syncytium-inducing capacity of human immunodeficiency virus isolates: frequent detection of syncytium-inducing isolates in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex.

Authors:  M Tersmette; R E de Goede; B J Al; I N Winkel; R A Gruters; H T Cuypers; H G Huisman; F Miedema
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

9.  Killing of primary CD4+ T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1.

Authors:  X Yu; M F McLane; L Ratner; W O'Brien; R Collman; M Essex; T H Lee
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

10.  Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization.

Authors:  A Koito; G Harrowe; J A Levy; C Cheng-Mayer
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  10 in total

1.  Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo.

Authors:  Y Kawano; Y Tanaka; N Misawa; R Tanaka; J I Kira; T Kimura; M Fukushi; K Sano; T Goto; M Nakai; T Kobayashi; N Yamamoto; Y Koyanagi
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection.

Authors:  Y Takahashi; Y Tanaka; A Yamashita; Y Koyanagi; M Nakamura; N Yamamoto
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype.

Authors:  E E Nakayama; Y Hoshino; X Xin; H Liu; M Goto; N Watanabe; H Taguchi; A Hitani; A Kawana-Tachikawa; M Fukushima; K Yamada; W Sugiura; S I Oka; A Ajisawa; H Sato; Y Takebe; T Nakamura; Y Nagai; A Iwamoto; T Shioda
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

4.  Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation.

Authors:  E Vicenzi; P P Bordignon; P Biswas; A Brambilla; C Bovolenta; M Cota; F Sinigaglia; G Poli
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

5.  Polymorphisms of RANTES and IL-4 genes in cerebral infarction.

Authors:  Jae-Young Um; Hyung-Min Kim
Journal:  J Mol Neurosci       Date:  2008-08-12       Impact factor: 3.444

6.  Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditions.

Authors:  Y Suzuki; Y Koyanagi; Y Tanaka; T Murakami; N Misawa; N Maeda; T Kimura; H Shida; J A Hoxie; W A O'Brien; N Yamamoto
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Cytoplasmic APOBEC3G restricts incoming Vif-positive human immunodeficiency virus type 1 and increases two-long terminal repeat circle formation in activated T-helper-subtype cells.

Authors:  Michael L Vetter; Richard T D'Aquila
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

8.  A novel combinatorial therapy with pulp stem cells and granulocyte colony-stimulating factor for total pulp regeneration.

Authors:  Koichiro Iohara; Masashi Murakami; Norio Takeuchi; Yohei Osako; Masataka Ito; Ryo Ishizaka; Shinji Utunomiya; Hiroshi Nakamura; Kenji Matsushita; Misako Nakashima
Journal:  Stem Cells Transl Med       Date:  2013-06-12       Impact factor: 6.940

Review 9.  Asymmetric HIV-1 co-receptor use and replication in CD4(+) T lymphocytes.

Authors:  Samanta A Mariani; Elisa Vicenzi; Guido Poli
Journal:  J Transl Med       Date:  2011-01-27       Impact factor: 5.531

10.  Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity.

Authors:  Michael L Vetter; Megan E Johnson; Amanda K Antons; Derya Unutmaz; Richard T D'Aquila
Journal:  PLoS Pathog       Date:  2009-02-06       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.